The U.S Food and Drug Administration is authorizing Regeneron's antibody cocktail for some patients who test positive for COVID-19. The FDA said Saturday that it's okay to give it to high-risk ...
Regeneron’s COVID-19 antibody cocktail, casirivimab and imdevimab, reduced the risk of death among hospitalized patients in a phase 3 trial, the drugmaker said June 16. The trial found that adding ...
HOUSTON, Texas (KTRK) -- One of the biggest ways COVID-19 is spreading is through our own households, from one family member to another. Now, a treatment is hoping to prevent the virus from spreading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback